Novel immunotherapy approach to treat cat allergy

Researchers brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system's allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.

source https://www.sciencedaily.com/releases/2021/02/210205104224.htm